VISBY MEDICAL, INC.
Doing business as VISBY MEDICAL INC
SAN JOSE, CA, 95134
Prime contracting experience
2 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | A RAPID, ACCURATE, POC DISPOSABLE INFLUENZA AND SARS-COV-2 MOLECULAR DIAGNOSTIC | — | $41,169,014 | May 29, 2026 | Feb 1, 2021 – Jun 30, 2026 |
| Prime | Department of Health and Human Services National Institutes of Health | RADX TECH - VISBY MEDICAL INC. FOR SINGLE-USE (DISPOSABLE), FULLY-INTEGRATED, RAPID, AUTOMATED RT-PCR IN VITRO DIAGNOSTIC TEST | — | $9,498,805 | Jun 30, 2023 | Sep 29, 2020 – Sep 28, 2022 |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Subcontracting experience
1 record from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Subcontractor | Department of Health and Human Services | VISBY MEDICAL IS THE MAKER OF AN INNOVATIVE INSTRUMENT-FREE, SINGLE USE PCR PLATFORM FOR THE DETECTION OF INFECTIOUS DISEASES. THEIR SEXUAL HEALTH TEST DETECTS CHLAMYDIA, GONORRHEA, AND TRICHOMONAS WITH ~97% ACCURACY IN LESS THAN 30 MINUTES. THIS TEST IS FDA AUTHORIZED FOR OVER THE COUNTER (OTC) USE WITHOUT THE NEED FOR A PRESCRIPTION. CARB-X FUNDING WILL ALLOW VISBY TO ADD THE DETECTION OF ANTIBIOTIC RESISTANCE TO THE SEXUAL HEALTH TEST, BY DEVELOPING OUR ASSAY FOR THE DETECTION OF A MUTATION IN THE GYRA GENE OF N. GONORRHOEAE THAT CONFERS RESISTANCE TO CIPROFLOXACIN. THE CDC LISTS ANTIBIOTIC RESISTANCE IN N. GONORRHOEAE AS ONE OF THE TOP 5 URGENT THREATS. DUE TO LACK OF A DIAGNOSTIC TEST RESULT FOR CIPROFLOXACIN RESISTANCE, CURRENT TREATMENT GUIDELINES RECOMMEND USING ONE OF THE LAST REMAINING ANTIBIOTICS (CEFTRIAXONE) AVAILABLE AGAINST GONORRHEA INFECTIONS. THE NEW VISBY TEST WILL HELP CLINICIANS KNOW WHEN CIPROFLOXACIN CAN BE USED WHICH CAN BE ADMINISTERED ORALLY AND WILL HELP TO CONSERVE OUR LAST LINES OF ANTIBIOTIC DEFENSE ONLY FOR THE CASES THAT REQUIRE IT. BY MAKING A SIMPLE, RAPID DIAGNOSTIC TEST FOR ANTIBIOTIC RESISTANCE, VISBY MEDICAL WILL PROVIDE A MUCH-NEEDED TOOL IN THE FIGHT AGAINST ANTIBIOTIC RESISTANCE. KC3697 Parent award context Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response Parent award NAICS: 541714 Parent award performance state: MA Parent award description: CARB-X GLOBAL ANTIBACTERIAL ACCELERATOR OTA View parent award on USAspending | — | $2,447,151 | Dec 7, 2023 | — – — |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Agencies supported
- Department of Health and Human ServicesGov-sourced
Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.